With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
An earlier flu season does not necessarily mean more cases overall, experts who question the popular narrative say.
HHS is expanding access through stockpiles that had been reserved for use in a future flu pandemic.
By several measures—including hospitalization rates—flu activity declined last week after an unusually early surge to the influenza season.
The guidance prioritizes the treatment of flu in high-risk patients amid shortages of the generic antiviral drug.
The US, Canada, and Mexico confirm high flu levels, and 9 European countries are reporting widespread activity.
As the holidays approach, the flu surge continues, and tracking shows a fresh spike in COVID-19 markers.
Amid rising flu activity causing decade-high hospitalization rates, COVID-19 markers are also climbing.
As hospitalizations almost double, most states are experiencing high or very high flu levels.
Global flu activity rose in the first half of November, mainly due to rising levels in North America and parts of Europe.
Flu activity is very high or high across most of the continental United States.
